Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

4 of 4 completed trials have results

Key Signals

1 recruiting4 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05685433Not ApplicableRecruiting

A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

Role: lead

NCT05882318Not ApplicableCompleted

Effectiveness of eCoin at Sensory and Subsensory Amplitudes

Role: lead

NCT03556891Not ApplicableCompleted

Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence

Role: lead

NCT03655054Not ApplicableCompleted

eCoin for OAB Feasibility Follow-on Study

Role: lead

NCT03029624Not ApplicableCompleted

eCoin Tibial Nerve Stimulation for OAB

Role: lead

NCT02926495Not ApplicableWithdrawn

Subcutaneous Median Nerve Neuromodulation For Drug-Treatment Resistant Hypertension.

Role: lead

All 6 trials loaded